Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-007866
Filing Date
2017-11-01
Accepted
2017-11-01 06:26:14
Documents
71
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20170930x10q.htm 10-Q 2129834
2 EX-10.1 qure-20170930ex101907353.htm EX-10.1 27333
3 EX-31.1 qure-20170930ex311249e18.htm EX-31.1 18378
4 EX-31.2 qure-20170930ex31296176c.htm EX-31.2 18266
5 EX-32.1 qure-20170930ex32138a93b.htm EX-32.1 11155
  Complete submission text file 0001558370-17-007866.txt   8231046

Data Files

Seq Description Document Type Size
6 EX-101.INS qure-20170930.xml EX-101.INS 1843207
7 EX-101.SCH qure-20170930.xsd EX-101.SCH 57980
8 EX-101.CAL qure-20170930_cal.xml EX-101.CAL 50202
9 EX-101.DEF qure-20170930_def.xml EX-101.DEF 256724
10 EX-101.LAB qure-20170930_lab.xml EX-101.LAB 506473
11 EX-101.PRE qure-20170930_pre.xml EX-101.PRE 417683
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 171167263
SIC: 2834 Pharmaceutical Preparations